COMMUNIQUÉS West-GlobeNewswire

Lancement par AliveCor du Kardia 12L alimenté par l’IA en Europe : le premier ECG portable à 12 dérivations au monde, doté d’une conception inédite à câble unique
15/04/2026
Désormais certifié CE, le système 12L utilise l’intelligence artificielle pour effectuer 35 diagnostics cardiaques, ce qui simplifie le processus d’ECG et facilite l’accès aux données cardiaques essentielles MOUNTAIN [...]
OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting
15/04/2026
Nantes, France, April 15, 2026 – 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , a clinical-stage biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno [...]
OSE Immunotherapeutics présentera un nouvel anticorps monoclonal, first-in-class, agoniste de FPR2 dans la résolution de l’inflammation chronique au Congrès 2026 de l’AAI
15/04/2026
Nantes, France, 15 avril 2026 – 7h30 CEST – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) , une société de biotechnologie au stade clinique développant des thérapies first-in-class en immuno-oncologie et [...]
Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes
15/04/2026
REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the pricing of [...]
BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026
15/04/2026
BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) -- Poster presentations to feature data from clinical asset BV100 addressing carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) hospital [...]
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
15/04/2026
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026 Halle (Saale) / Munich, Germany, April 15 , 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; [...]
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
15/04/2026
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive [...]
LECOM Makes Pharmacy Education More Accessible with Three Fully Accredited Doctor of Pharmacy Pathways
15/04/2026
Bradenton, FL, April 14, 2026 (GLOBE NEWSWIRE) -- Lake Erie College of Osteopathic Medicine (LECOM) is reinforcing its commitment to accessible and affordable pharmacy education by offering three fully accredited Doctor [...]
Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock
15/04/2026
WALTHAM, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose [...]
Arc TRT Launches New Website to Help UK Men Access Personalised Testosterone Replacement Therapy
15/04/2026
Southampton-based private clinic goes online with a straightforward, patient-first platform designed to make TRT more accessible across the UK Southampton, UK, April 15, 2026 (GLOBE NEWSWIRE) -- There are a lot of men [...]
MindBio Appoints Market Maker Venture Liquidity Providers
15/04/2026
VANCOUVER, British Columbia, April 14, 2026 (GLOBE NEWSWIRE) -- MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company commercializing AI-driven [...]
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
15/04/2026
SOUTH SAN FRANCISCO, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced the pricing of an underwritten public offering of 87,500,000 shares of its common stock at a [...]
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14/04/2026
FOSTER CITY, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it granted an equity award in the form of a stock option to [...]
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
14/04/2026
BURLINGTON, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. [...]
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
15/04/2026
MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient has been dosed with TLX101-Tx (¹³¹I- [...]
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
14/04/2026
Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information technology (“HIT”) company focused on advancing electrocardiography [...]
UPDATE - R1 Announces Phare OS Expansion to Help Providers Navigate Growing Complexity and Margin Pressure
14/04/2026
Launches New Denials Management Solution as R1 Opens R37 Lab in New York City CHICAGO, April 14, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, today shared the [...]
Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel
14/04/2026
SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
Enlitic Announces Ensight 2.2, a Breakthrough in Imaging Data Standardization
14/04/2026
New release builds on Ensight 2.1 with greater visibility, faster performance, and a more precise way to help health systems and partners deliver imaging data across systems LOVELAND, Colo., April 14, 2026 (GLOBE [...]

Pages